Literature DB >> 24616407

P-glycoprotein-dependent trafficking of nanoparticle-drug conjugates.

Erik C Dreaden1, Idris O Raji, Lauren A Austin, Shaghayegh Fathi, Sandra C Mwakwari, William H Humphries, Bin Kang, Adegboyega K Oyelere, Mostafa A El-Sayed.   

Abstract

Entities:  

Keywords:  colloids; gold; nanoparticles; nanorods; nanotechnology

Mesh：

Substances：

Year:  2014        PMID： 24616407      PMCID： PMC4136971          DOI： 10.1002/smll.201303190

Source DB:  PubMed          Journal:  Small        ISSN： 1613-6810            Impact factor:   13.281


× No keyword cloud information.
  43 in total

1.  Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils.

Authors:  D Vazifeh; A Preira; A Bryskier; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

Review 2.  Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies.

Authors:  Panayiotis P Constantinides; Kishor M Wasan
Journal:  J Pharm Sci       Date:  2007-02       Impact factor: 3.534

3.  MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine.

Authors:  A van Helvoort; A J Smith; H Sprong; I Fritzsche; A H Schinkel; P Borst; G van Meer
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

4.  Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin.

Authors:  Martina Bosnar; Zeljko Kelnerić; Vesna Munić; Vesna Eraković; Michael J Parnham
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  In vitro and in vivo antibacterial activities of the tricyclic ketolide TE-802 and its analogs.

Authors:  Takeo Ono; Masato Kashimura; Keiko Suzuki; Rika Oyauchi; Junko Miyachi; Hiroshi Ikuta; Hiroyuki Kawauchi; Toshi Akashi; Toshifumi Asaka; Shigeo Morimoto
Journal:  J Antibiot (Tokyo)       Date:  2004-08       Impact factor: 2.649

6.  Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol.

Authors:  G D Luker; K R Nilsson; D F Covey; D Piwnica-Worms
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

7.  Cholesterol homeostasis. Modulation by amphiphiles.

Authors:  Y Lange; T L Steck
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

8.  Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.

Authors:  T Iwahashi; E Okochi; K Ariyoshi; H Watabe; E Amann; S Mori; T Tsuruo; K Ono
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

9.  Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture.

Authors:  M B Carlier; I Garcia-Luque; J P Montenez; P M Tulkens; J Piret
Journal:  Int J Tissue React       Date:  1994

Review 10.  P-glycoprotein: from genomics to mechanism.

Authors:  Suresh V Ambudkar; Chava Kimchi-Sarfaty; Zuben E Sauna; Michael M Gottesman
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867
View more
  4 in total

1.  Design, synthesis and evaluation of antiproliferative activity of melanoma-targeted histone deacetylase inhibitors.

Authors:  Idris Raji; Kabir Ahluwalia; Adegboyega K Oyelere
Journal:  Bioorg Med Chem Lett       Date:  2017-01-17       Impact factor: 2.823

2.  Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates.

Authors:  Alex George; Idris Raji; Bekir Cinar; Omer Kucuk; Adegboyega K Oyelere
Journal:  Bioorg Med Chem       Date:  2018-02-16       Impact factor: 3.641

Review 3.  Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types.

Authors:  Longfa Kou; Yangzom D Bhutia; Qing Yao; Zhonggui He; Jin Sun; Vadivel Ganapathy
Journal:  Front Pharmacol       Date:  2018-01-26       Impact factor: 5.810

Review 4.  Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.

Authors:  Priya Yadav; Suresh V Ambudkar; N Rajendra Prasad
Journal:  J Nanobiotechnology       Date:  2022-09-24       Impact factor: 9.429
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.